NVLX NEWS QUOTE ~~~" Kenneth L Waggoner, Nuvilex's CEO and President, commented, "These meetings were important and essential in cementing our plans for developing treatments for serious and deadly diseases like cancer and diabetes through the use of the cellulose-based live cell encapsulation technology. In that vein, we are extremely grateful to Drs. Gunzburg and Salmons for traveling from Singapore to join us in them and for agreeing to work closely with us in our efforts to employ the technology that they have developed."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.